You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 1, January 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Coexistence of Myeloid Metaplasia With Myelofibrosis and Hairy-Cell Leukemia

Vadakkencheri P. Subramanian, MD; German A. Gomez, MD; Tin Han, MD; Untae Kim, MD; Jun Minowada, MD; Avery Sandberg, MD

Arch Intern Med. 1985;145(1):164-166.


Abstract

• A 42-year-old man with severe pancytopenia and myelofibrosis underwent splenectomy seven months after onset of his symptoms; the leukocyte, platelet, and hematocrit levels became normal. Myeloid metaplasia was identified in the liver and spleen. Progressive lymphocytosis started eight months after splenectomy, and after 66 months a florid hairy-cell leukemia was diagnosed; the circulating cells were B type with µ{kappa} surface markers. Anemia and thrombocytopenia reappeared and were controlled initially with daily prednisone; chlorambucil was later added. At that time, the peripheral blood had more than 150 megaloblastoid-appearing normoblasts per 100 leukocytes. The PAS stain was positive in 95% to 100% of these cells; the B-cell surface markers were no longer identified. Further treatment failed to control the lymphoproliferative and myeloproliferative syndromes; the patient died 99 months after splenectomy. On autopsy, infiltration by hairy-cell leukemia cells and erythroid precursors was observed in the bone marrow, liver, lymph nodes, and other organs.

(Arch Intern Med 1985;145:164-166)



Author Affiliations

From the Departments of Medical Oncology (Drs Subramanian, Gomez, and Han), Pathology (Dr Kim), Immunology (Dr Minowada), and Genetics and Endocrinology (Dr Sandberg), Roswell Park Memorial Institute, Buffalo. Dr Subramanian is now with the Veterans Administration Medical Center, Temple, Tex; Dr Minowada is now with the Department of Pathology, VA Medical Center, Hines, Ill.


Footnotes

Accepted for publication Jan 17,1984.

Reprint requests to Department of Medical Oncology, Roswell Park Memorial Institute, 666 Elm St, Buffalo, NY 14263 (Dr Gomez).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.